Healthcare Press Releases

New Report Available: Low-Grade Glioma Global Clinical Trials Review, H1, 2014

GlobalData's clinical trial report, "Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Low-Grade Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

TruMantra Schools: A Leader in Providing Integrative Approach to Massage Therapy Education

Touch the body. Calm the mind. Heal the Spirit. These what makes massage therapy a holistic approach. It does not only soothe one’s body pains, it also brings inner peace.

Middle East Emergency Exhibition & Conference to Be Launched in Dubai in June 2014

Increasing pressure on emergency services in the region has made the implementation of strategies to streamline multi-agency response to emergencies, and to more effectively coordinate disaster management, absolutely necessary. This year, for the first time, the Middle East Emergency Medicine Exhibition and Conference will be held alongside the 6th edition of Hospital Build & Infrastructure Middle East in Dubai, UAE, from 2-4 June 2014 at the Dubai International Convention & Exhibition Centre.

Raspberry Ketone Max - The Most Effective Weight Loss Supplement Now Offers Huge Discount Online

LogoRaspberry Ketone Max is one of the most effective weight loss supplements that have achieved highest selling figures. The product is the complete weight loss solution which delivers great weight loss results along with several positive effects on overall health. Presently, Raspberry Ketone Max is available with a special promotional offer. The company has announced to offer an additional supply of the product, which will include a few packages of Raspberry Ketone Max. Such packages are easily available on the official website of the Raspberry Ketone Max. The maximum order that one can place is six month package which includes six bottles of Raspberry Ketone Max. In this package, customers can get extra 3 bottles free of cost and save up to 50%. This is the special promotion offer that is available for a limited time.

Yacon Molasses - The 100% Pure and Organic Yacon Syrup for Sale Online With Extra Discount Offers

LogoYacon Syrup is the latest discovery by ongoing scientific research in the weight loss industry. The natural substance obtained from a plant carries lots of health benefits including the weight loss abilities. For its several health beneficial abilities, it has been widely used by the weight loss industry in dietary supplement. The recently launched Yacon Molasses supplement contains 100% pure Yacon Syrup Extract and has proven to be the effective supplement to provide visible weight loss results in just 4 weeks. Several clinical studies have been conducted that provide the medical backings to the weight loss claims of Yacon Molasses.

Zeta Clear - The Most Effective Nail Fungus Treatment Solution Now Offers Extra Discount Online

LogoEveryone wants to get rid of nail fungus and have beautiful nails. There are homeopathic remedies to treat this condition, but there is still one thing that works better than all available methods. Zetaclear is the ultimate solution which combines a homeopathic approach and modern science to remove nail fungus and grow stronger nails. The product utilizes all natural herbal extracts and oils that have long been used for their healing properties. It works from the inside out to address multiple symptoms of nail fungus and provides immediate relief without harming the skin around the nails. It takes four to six weeks of using Zetaclear to completely eliminate the nail fungus and grow healthy nails.

Idol Lash - The Most Selling Eye Lashes Growth Enhancer Serum Now Offers Extra Discount

LogoA majority of women wants to achieve longer and thicker eyelashes like their favorite celebrity, for this purpose, they dip into their purse buying beauty tools and make up. But this process can be quite expensive, considering the eyelash expansion treatments that promise to offer long and thick eyelashes. Idol Lash is the newest innovation in the cosmetic industry which steps beyond simply lengthening and darkening the eyelashes. It can help women achieve long, thick and beautiful looking eyelashes as well as nourishes the lash with natural nutrients, all without the need to go through surgical treatment. It is the ultimate eyelash enhancer that gives longer lasting results, unlike normal mascaras.

The Ultimate Herpes Protocol Review: Scam or Legit? Should People Trust This Herpes Remedy by Melanie Addington

Herpes virus has become a worldwide concern since a massive amount of people are struggling to get rid of this dreadful kind of STD. Having herpes can be a nightmare for many people. This viral disease can be caused through herpes simplex virus type 1 and type 2. Sexual contact with the infected person leads to the formation of genital herpes. Among the many symptoms of herpes, infection on the skin or mucosa, having headache and pain in some parts of the body are usually the most common ones. Sufferers of this awful disease tend to remain hidden as they are embarrassed to let others find what have been going through. This stigmatization or feeling of being disgraced by others makes herpes infection even worse.

Venus Factor System Review: John Barbar Has Published His Incredible Fat and Weight Loss System Which Is Exclusively for Women

The Venus Factor System is an new revolutionary product developed for helping women worldwide lose weight and gain a bikini body. The Venus Factor System Review aims helping customers to decide whether investing or not their saving to get The Venus Factor System new revolutionary weight loss program designed for women. Customers who are looking to purchase this new system called The Venus Factor System are on this page because they are looking for more information and description that the product has. This is why Daily Gossip Magazine reviewed The Venus Factor System guide for helping people to find more information, description, features and customer reviews.

US Businesses: Key Players in Lymphedema Treatment Act Approval

LogoApproximately 10 million Americans and more than 100 million people all over the world suffer from lymphedema. It is a painful and chronic swelling of the lymph nodes which may possibly have an impact on as much as 70 percent of women who have surgery or received chemotherapy for breast cancer. Men who have went have underwent prostate cancer surgery may experience it as well.

Liposuction Choices Explained by Dr Barry Lycka in Latest Video

LogoLiposuction choices in 2014 and the background to the changes in technology used for liposuction are the subject of the latest educational video from Edmonton cosmetic dermatologist Dr Barry Lycka.

"France Pharmaceuticals & Healthcare Report Q2 2014" Published

LogoA number of biologics will lose patent protection between now and 2015, which means that France's biosimilar substitution legislation will pave the way to cost savings in the healthcare system. However, we question the strength of this legislation, as development and manufacturing costs for these products are high and therefore actual cost savings secured through biosimilars may ultimately be limited. Furthermore, ongoing safety concerns may act as a barrier to the prescription of biosimilars

Market Report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea", Published

LogoGlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2013, South Korea's population was approximately at 50.2 million. It has one of the world's highest population densities. The South Korean government has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the South Korean regulatory authorities recently made changes to the regulatory bodies overseeing the pharmaceutical and wider medical sectors, to provide a transparent, strong and efficient regulatory system to facilitate faster approval of pharmaceutical products and medical devices. The South Korean pharmaceutical market is one of the largest in Asia, estimated to be worth $18.6 billion in 2013 and expected to reach $24.3 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.9% over the 2008-2020 period. The medical device market was valued at $3.3 billion in 2008 and is expected to reach approximately $6.3 billion by 2020, at a projected CAGR of 5.5%. These positive trends can primarily be attributed to:

New Market Study Published: Chronic Heart Failure - Pipeline Review, H1 2014

LogoGlobal Markets Direct's, 'Chronic Heart Failure - Pipeline Review, H1 2014', provides an overview of the Chronic Heart Failure's therapeutic pipeline.

Report Published: "Vectura Group Plc - Product Pipeline Review - 2014"

LogoGlobal Markets Direct's, 'Vectura Group plc - Product Pipeline Review - 2014', provides an overview of the Vectura Group plc's pharmaceutical research and development focus.

Market Report, "Systemic Lupus Erythematosus - Pipeline Review, H1 2014", Published

LogoGlobal Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H1 2014', provides an overview of the Systemic Lupus Erythematosus's therapeutic pipeline.

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014: New Research Report Available at Fast Market Research

LogoGlobalData's clinical trial report, "Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

New Market Research Report: Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014

LogoGlobal Markets Direct's, 'Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014', provides an overview of the Arromax Pharmatech, Co. Ltd.'s pharmaceutical research and development focus.

Recently Released Market Study: Leiomyosarcoma Global Clinical Trials Review, H1, 2014

LogoGlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 - New Market Report

LogoGlobalData's clinical trial report, "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

New Market Research Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014

LogoGlobal Markets Direct's, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014', provides an overview of the Gastrointestinal Stromal Tumor (GIST)'s therapeutic pipeline.

Recent Study: Chronos Therapeutics Limited - Product Pipeline Review - 2014

LogoGlobal Markets Direct's, 'Chronos Therapeutics Limited - Product Pipeline Review - 2014', provides an overview of the Chronos Therapeutics Limited's pharmaceutical research and development focus.

New Market Research Report: Malignant Mesothelioma Global Clinical Trials Review, H1, 2014

LogoGlobalData's clinical trial report, "Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Mesothelioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

"Scabies Global Clinical Trials Review, H1, 2014" Is Now Available at Fast Market Research

LogoGlobalData's clinical trial report, "Scabies Global Clinical Trials Review, H1, 2014" provides data on the Scabies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Scabies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Scabies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014: New Research Report Available at Fast Market Research

LogoGlobal Markets Direct's, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014', provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)'s therapeutic pipeline.

Dr. Thomas Lambert Caters to Specialized Dental Needs of Musicians

LogoCombining his knowledge of wind instrument playing and dentistry allows Dr. Lambert to offer a service that simply cannot be found in other dental practices. Musicians have very specialized needs when they use their mouths to play a musical instrument. The smallest change in a bite, tooth or jaw position, tooth shape, or tongue movement can significantly impact how a musician can play, and the dentist must understand and pay special attention to these problems. A trumpet player with a chipped front tooth can have the tooth restored with composite bonding to make it look great from a cosmetic standpoint but might ruin his playing career. A horn player may get beautiful porcelain veneers that may add half a millimeter to the length of the teeth but may wipe out the musician’s ability to play really high notes in his upper range. Even wind players with removable dentures may experience problems with range, sound quality, and air pressure or airflow issues into their horn.

G3 Bankruptcy Fraud Investigator Discloses Findings of Insider Probe for Companies Pure De-Lite Chocolate, the-Phoenix-Cookie & Yurika-Foods

LogoAs the category creator and world leader in healthy chocolate, the true vision of Xoçai is to transform and improve individual lives worldwide through its exclusive and healthy chocolate products. One such unique element is XoVita™, a proprietary high-antioxidant blend of cacao, açaí berries and blueberries, an ingredient combination exclusive to Xoçai. This proprietary and exclusive high-antioxidant blend is utilized in all of Xoçai products and provides a wide-ranging class of nutrients, vitamins and health benefits. XoVita™ consistently contributes to the findings that all of Xocai’s products contain the highest ORAC (antioxidant-measuring test) and flavonoid rich products available today. (mxicorp.com/xovita/)